Disposable Blood Transfusion

Disposable Blood Transfusion Market Outlook

The global disposable blood transfusion market was valued at approximately USD 4.5 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of around 8.2% from 2023 to 2035. The increasing prevalence of blood-related disorders, along with the growing demand for safe and efficient blood transfusion practices, are significant factors contributing to this growth. Additionally, advancements in blood transfusion technologies and the rising number of surgical procedures worldwide are further fuelling demand for disposable blood transfusion products. Moreover, the growing elderly population, who are more susceptible to blood-related conditions, is also expected to drive the market growth significantly in the coming years.

Growth Factor of the Market

The disposable blood transfusion market is fundamentally driven by the rising incidence of chronic diseases such as cancer, hemophilia, and anemia, which require frequent blood transfusions for management and treatment. Furthermore, the increasing awareness regarding the importance of safe blood transfusion practices has led to stringent regulations and guidelines governing the use of disposable blood transfusion products. This is becoming particularly important in countries that are enhancing their healthcare infrastructure to meet global standards. Another contributing factor is the technological advancements in blood transfusion equipment, ensuring enhanced safety, minimal risk of contamination, and better patient outcomes. The growing trend toward outpatient care and at-home medical treatments is further propelling the demand for convenient and disposable blood transfusion solutions. Additionally, government initiatives aimed at bolstering blood donation and transfusion systems are also expected to create a conducive environment for market growth.

Key Highlights of the Market

• Increasing prevalence of chronic conditions necessitating blood transfusions.
• Technological advancements improving safety and efficiency in blood transfusion processes.
• Growing trend towards homecare and outpatient services driving demand for disposable solutions.
• Rising awareness and stringent regulations concerning safe blood transfusion practices.
• Government initiatives focusing on enhancing blood donation and transfusion systems.

By Product Type

Blood Bags:

Blood bags are a crucial component in the disposable blood transfusion market, designed to safely collect, store, and transport blood. The increasing need for blood transfusions, particularly in emergencies and surgical procedures, is significantly driving the demand for blood bags. Innovations in blood bag technology, such as the development of multi-chamber bags, have enhanced storage capabilities and improved the shelf life of collected blood. Furthermore, the rise in blood donation campaigns has increased the supply of blood bags to ensure effective storage and distribution. The convenience of disposing of single-use bags after a transfusion is also a significant factor contributing to their growing popularity in hospitals and clinics around the world.

Blood Filters:

Blood filters play a critical role in ensuring the safety and quality of blood transfusions by removing impurities and particulate matter from the blood before administration. With the rising focus on patient safety, the demand for blood filters has been on the rise, particularly in developed regions with stringent healthcare regulations. These filters help reduce the risk of transfusion reactions and improve overall blood quality, which is essential for effective treatment outcomes. Moreover, advancements in filter technology that enhance filtration efficiency and ease of use are expected to further boost market growth in this segment. The increasing number of blood transfusion procedures in hospitals and surgical centers contributes significantly to the demand for disposable blood filters.

Blood Lancets:

Blood lancets are essential devices used to obtain blood samples for various medical tests, including glucose monitoring and blood typing. The growing prevalence of diabetes and other chronic illnesses requiring frequent blood testing has led to a surge in demand for blood lancets. These devices are designed to minimize patient discomfort while ensuring accurate sampling. Furthermore, the rising trend of self-monitoring of health conditions, particularly in diabetic patients, is propelling the market for disposable blood lancets. The convenience and safety of using single-use lancets also support their widespread adoption in both clinical and homecare settings.

Blood Administration Sets:

Blood administration sets are designed to facilitate the safe delivery of blood products to patients during transfusions. The increasing complexity of medical treatments and the rising number of transfusion procedures are driving the demand for efficient and reliable administration sets. These sets are equipped with various features, such as filters and air vents, to ensure optimal safety and performance during the transfusion process. The continuous development of advanced administration sets with enhanced safety mechanisms is projected to further elevate market growth. Additionally, the emphasis on minimizing transfusion-related complications in hospitals is pushing the adoption of disposable blood administration sets.

Blood Collection Tubes:

Blood collection tubes are widely used in laboratories for sample collection, storage, and transportation. The rising number of diagnostic tests and laboratory procedures is significantly boosting the demand for these tubes. Innovations in blood collection tube technology, such as the introduction of additive tubes that preserve blood samples for specific tests, have enhanced their utility in clinical settings. Furthermore, the growing trend towards preventive healthcare and early disease detection is leading to an increase in blood sample collection, thus driving the market for disposable blood collection tubes. The convenience of using single-use tubes that eliminate the risk of cross-contamination is also a significant factor in their widespread adoption.

By Application

Hospitals:

Hospitals represent a significant application segment for disposable blood transfusion products, attributed to the high volume of surgical procedures and emergency care that often require blood transfusions. The growing patient population and the increase in the number of hospitals worldwide have led to an increased demand for safe and efficient blood transfusion solutions. Hospitals focus on adopting disposable products to minimize the risk of infection and ensure patient safety, thus driving the consumption of disposable blood transfusion products. Moreover, advancements in hospital infrastructure and technology have further streamlined the blood transfusion process, promoting the use of disposable options.

Clinics:

Clinics, both private and public, have become important consumers of disposable blood transfusion products due to their growing role in providing outpatient care and minor surgical procedures. The increasing emphasis on patient safety and the reduction of cross-contamination risks are leading clinics to opt for disposable products. Furthermore, the rising number of chronic disease cases that require regular monitoring and treatment in clinic settings is propelling the demand for blood lancets, collection tubes, and administration sets. The convenience and cost-effectiveness of using disposable products in clinics are further encouraging their adoption.

Blood Banks:

Blood banks are vital in the healthcare system, responsible for collecting, testing, and storing blood. The demand for disposable blood transfusion products is particularly high in blood banks due to the need for safe and sterile collection and storage procedures. Innovations in blood bag technology and the introduction of multi-chamber bags specifically designed for blood banks have enhanced the efficiency of blood storage and distribution. The growing awareness about the importance of blood donation and the establishment of new blood banks globally are contributing to the expansion of this market segment, further driving demand for disposable products.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are increasingly utilizing disposable blood transfusion products due to the rise in outpatient surgeries that often require immediate blood access. The focus on patient safety and efficient care in ASCs has led to the adoption of disposable blood products to minimize infection risks. ASCs are experiencing growth due to the shift towards outpatient care, which is also propelling the demand for equipment like blood filters and administration sets. The increasing prevalence of day surgeries and the need for rapid and efficient blood transfusion systems are driving the market for disposable blood transfusion products in this segment.

Homecare:

The homecare segment is witnessing substantial growth as more patients prefer receiving medical care at home, especially those requiring frequent blood monitoring or transfusions. This shift is being supported by advancements in medical devices that facilitate safe and efficient blood transfusions in home settings. Disposable blood transfusion products are particularly appealing in homecare due to their convenience and reduced risk of cross-contamination. The growing population of elderly individuals needing regular medical treatment at home is also contributing to the rising demand within this segment. Furthermore, the increasing trend of telehealth and remote patient monitoring is enhancing the opportunities for disposable blood transfusion products in the homecare market.

By Distribution Channel

Hospital Pharmacies:

Hospital pharmacies serve as a crucial distribution channel for disposable blood transfusion products, ensuring that hospitals have immediate access to these essential items. The rising number of surgeries and emergency care procedures within hospitals drives the demand for efficient inventory management of disposable blood products. Hospital pharmacies typically stock a wide range of products, including blood bags, administration sets, and filters, to ensure comprehensive care. The increasing focus on patient safety and quality control in hospital pharmacies further promotes the utilization of disposable blood transfusion products, ensuring that patients receive safe and effective treatment.

Online Pharmacies:

The growth of online pharmacies has created a convenient distribution channel for disposable blood transfusion products, allowing healthcare professionals and patients to easily access these necessary items. The increasing acceptance of e-commerce in the healthcare sector, combined with the rising demand for at-home medical solutions, has led to a significant uptick in online pharmacy sales. Patients can easily order disposable blood transfusion products from the comfort of their homes, which is particularly beneficial for those requiring frequent blood monitoring. Furthermore, the trend of telemedicine is contributing to the growth of online pharmacies as healthcare providers increasingly recommend home-based monitoring and treatment solutions.

Retail Pharmacies:

Retail pharmacies play an essential role in distributing disposable blood transfusion products, catering to patients and healthcare professionals who require immediate access to these items. The growing emphasis on preventive healthcare and early detection of diseases is increasing the demand for blood monitoring devices and supplies. Retail pharmacies are well-positioned to offer a range of disposable blood products, including blood lancets and collection tubes, to cater to the needs of the general public. The convenience of purchasing disposable blood transfusion products at retail pharmacies is driving their popularity among patients who prefer to manage their health conditions independently.

Blood Transfusion Centers:

Blood transfusion centers are specialized facilities that are critical in collecting and storing blood. They require a consistent supply of disposable blood transfusion products to support their operations effectively. The growing number of blood donation drives and the increasing focus on enhancing blood donor safety are driving the demand for these products in blood transfusion centers. The emphasis on sterile and safe blood collection processes is leading to a rise in the adoption of disposable products, ensuring that blood is collected, stored, and distributed without any risk of contamination. Furthermore, these centers are continually evaluating and adopting new technologies to enhance their operations, further driving demand for disposable blood transfusion products.

Others:

This category includes various other distribution channels such as specialty healthcare stores and direct sales through manufacturers. The demand for disposable blood transfusion products through these channels is driven by the increasing need for specialized healthcare solutions and the growing awareness of safe blood transfusion practices. Specialty healthcare stores often cater to specific medical needs, providing a niche market for disposable blood products. Direct sales from manufacturers allow for tailored solutions and bulk purchases, which can be advantageous for healthcare facilities. As the market evolves, these alternative distribution channels are expected to become increasingly significant in meeting the demand for disposable blood transfusion products.

By Material Type

Plastic:

Plastic is the most widely used material for disposable blood transfusion products due to its lightweight, flexible, and cost-effective properties. The advantages of using plastic for blood bags, filters, and administration sets include excellent impermeability and resistance to chemical reactions, ensuring the safe storage and transport of blood. The increasing focus on patient safety and the need for sterile products are driving the demand for plastic-based blood transfusion products. Furthermore, advancements in plastic manufacturing techniques are leading to the development of more durable and efficient disposable blood products, thereby promoting their widespread adoption in healthcare settings.

PVC:

Polyvinyl chloride (PVC) is another key material used for producing disposable blood transfusion products. PVC offers a combination of strength, flexibility, and biocompatibility, making it an ideal choice for blood bags and administration sets. The inherent properties of PVC, such as its ability to be sterilized effectively, contribute to its popularity in the medical field. With increasing regulations emphasizing safety and quality in blood transfusion processes, the demand for PVC products is expected to grow, particularly in regions with advanced healthcare systems. Additionally, the development of non-toxic and phthalate-free PVC formulations is set to enhance the market appeal of PVC-based disposable blood transfusion products.

Polyethylene:

Polyethylene is also utilized in the manufacture of various disposable blood transfusion products due to its excellent chemical resistance and clarity. This material is commonly used for blood collection tubes, offering a safe medium for storing and transporting blood samples. The demand for polyethylene-based products is supported by the increasing number of diagnostic tests and laboratory procedures requiring accurate blood sampling. Additionally, polyethylene's lightweight nature and cost-effectiveness make it an attractive option for healthcare providers. As research continues to advance the capabilities of polyethylene materials, it is likely to see increased usage in disposable blood transfusion products.

Others:

This category encompasses various alternative materials used for disposable blood transfusion products, including co-polymer blends and specialized materials designed for specific applications. The usage of these alternative materials is driven by the growing demand for innovative solutions that enhance the performance and safety of blood transfusion products. For instance, some manufacturers are developing materials that offer better barrier properties, extended shelf life, and improved compatibility with blood components. The continuous evolution and research into new materials are expected to provide manufacturers with opportunities to create advanced disposable blood transfusion products that meet the diverse needs of healthcare providers.

By Region

North America holds a significant share of the disposable blood transfusion market, driven by advanced healthcare infrastructure, high prevalence of chronic diseases, and robust blood donation systems. The region is expected to maintain its dominance throughout the forecast period, with a projected CAGR of approximately 7.5%. The presence of leading market players and continuous innovations in blood transfusion technologies further contribute to market growth in North America. Additionally, the increasing acceptance of outpatient care and home-based medical solutions is likely to enhance the demand for disposable blood transfusion products in this region.

Europe also represents a significant market for disposable blood transfusion products, supported by the increasing focus on healthcare quality and patient safety. The region has seen substantial investments in healthcare infrastructure, particularly in Eastern Europe, which is expected to boost the demand for blood transfusion products. With rising awareness regarding safe blood transfusion practices and governmental initiatives aimed at enhancing blood donation rates, Europe is anticipated to experience steady growth in this market segment. The combined market share of the European region along with North America is expected to surpass USD 6 billion by 2035.

Opportunities

The disposable blood transfusion market is ripe with opportunities, primarily driven by the increasing prevalence of chronic diseases that require regular blood transfusions. As the global population ages, there is a heightened demand for medical procedures that necessitate blood products, presenting a lucrative opportunity for manufacturers of disposable blood transfusion products. Furthermore, as healthcare shifts towards outpatient and home-based care, there is significant potential for growth in the homecare segment. Companies that focus on developing innovative, user-friendly products can tap into this expanding market and cater to the needs of patients who require frequent blood monitoring and transfusions at home. Additionally, emerging markets in Asia and Latin America present new avenues for growth as healthcare systems continue to evolve and improve their blood transfusion capabilities.

Moreover, advancements in technology are creating novel opportunities for the disposable blood transfusion market. The integration of digital solutions, such as smart blood monitoring systems, is enhancing patient care and safety. Companies that invest in research and development to create technologically advanced blood transfusion products are likely to gain a competitive edge in the market. Collaborations and partnerships between manufacturers and healthcare providers can also lead to the development of tailored solutions that address specific patient needs. Overall, the market is set to benefit from ongoing technological innovations, increasing awareness of safe blood transfusion practices, and the expanding scope of healthcare services worldwide.

Threats

Despite the promising growth trajectory of the disposable blood transfusion market, several threats could impede progress. One of the most significant challenges is the increasing competition among manufacturers, leading to price wars that may affect profit margins. Additionally, the presence of alternative blood transfusion methods, such as cell salvage and blood substitutes, poses a substantial threat to the adoption of traditional disposable blood transfusion products. The development of advanced technologies may divert resources and attention from established disposable solutions, potentially limiting market growth. Furthermore, regulatory challenges and stringent compliance requirements in various regions can pose barriers to market entry for new players.

Another critical threat to the market is the risk of contamination and safety concerns associated with disposable blood products. Incidents of product recalls and safety violations can erode consumer trust and negatively impact sales. Manufacturers must invest in stringent quality control measures and adhere to international standards to mitigate these risks. Economic fluctuations can also affect healthcare budgets, leading to reduced spending on disposable products, particularly in developing countries. As such, manufacturers must remain vigilant and adaptable to navigate these threats effectively and sustain their market presence.

Competitor Outlook

• Terumo Corporation
• Becton, Dickinson and Company
• Fresenius Kabi AG
• Cardinal Health, Inc.
• Haemonetics Corporation
• Grifols S.A.
• Mediware Information Systems, Inc.
• Macopharma
• Blood Centers of America, Inc.
• JMS Co., Ltd.
• Shenzhen Dapeng Pharmaceutical Co., Ltd.
• Medline Industries, Inc.
• Graham-Field Health Products, Inc.
• SCW Medicath
• Biolife Plasma Services

The competitive landscape of the disposable blood transfusion market is characterized by the presence of several key players, each vying for market share through technological innovation and strategic partnerships. Companies are increasingly focusing on product development and diversification to meet the growing demand for safe and effective blood transfusion solutions. Furthermore, collaborations with healthcare providers and research institutions are becoming a common strategy to enhance product offerings and develop advanced technologies. The emphasis on improving patient safety and minimizing transfusion-related complications is driving companies to invest in research and development, leading to innovative solutions that cater to the needs of healthcare professionals and patients alike.

Among the major players, Terumo Corporation stands out with a comprehensive portfolio of disposable blood transfusion products, including blood bags and administration sets. The company has consistently prioritized innovation and quality, allowing it to maintain a strong market presence. Similarly, Becton, Dickinson and Company leverages its extensive distribution network and strong brand reputation to deliver a wide range of medical devices, including blood transfusion products. The company is known for its commitment to safety and quality, consistently meeting international standards for medical devices.

Fresenius Kabi AG is another significant player in the disposable blood transfusion market, well-regarded for its innovative solutions and focus on healthcare quality. The company invests heavily in research and development to enhance its product offerings, particularly in the areas of blood storage and administration. Cardinal Health, Inc. is also a key competitor, offering a comprehensive range of disposable blood transfusion products and solutions that cater to healthcare providers. The company's strategic focus on operational efficiency and customer satisfaction has positioned it favorably in the market. Haemonetics Corporation, known for its advanced blood management solutions, is actively pursuing opportunities to expand its footprint in the disposable blood transfusion market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Macopharma
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Grifols S.A.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 SCW Medicath
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 JMS Co., Ltd.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Fresenius Kabi AG
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Terumo Corporation
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Cardinal Health, Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Biolife Plasma Services
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Haemonetics Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Medline Industries, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Becton, Dickinson and Company
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Blood Centers of America, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Graham-Field Health Products, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Mediware Information Systems, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Shenzhen Dapeng Pharmaceutical Co., Ltd.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Disposable Blood Transfusion Market, By Application
    • 6.1.1 Hospitals
    • 6.1.2 Clinics
    • 6.1.3 Blood Banks
    • 6.1.4 Ambulatory Surgical Centers
    • 6.1.5 Homecare
  • 6.2 Disposable Blood Transfusion Market, By Product Type
    • 6.2.1 Blood Bags
    • 6.2.2 Blood Filters
    • 6.2.3 Blood Lancets
    • 6.2.4 Blood Administration Sets
    • 6.2.5 Blood Collection Tubes
  • 6.3 Disposable Blood Transfusion Market, By Material Type
    • 6.3.1 Plastic
    • 6.3.2 PVC
    • 6.3.3 Polyethylene
    • 6.3.4 Others
  • 6.4 Disposable Blood Transfusion Market, By Distribution Channel
    • 6.4.1 Hospitals Pharmacies
    • 6.4.2 Online Pharmacies
    • 6.4.3 Retail Pharmacies
    • 6.4.4 Blood Transfusion Centers
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Disposable Blood Transfusion Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Disposable Blood Transfusion market is categorized based on

By Product Type

• Blood Bags
• Blood Filters
• Blood Lancets
• Blood Administration Sets
• Blood Collection Tubes

By Application

• Hospitals
• Clinics
• Blood Banks
• Ambulatory Surgical Centers
• Homecare

By Distribution Channel

• Hospitals Pharmacies
• Online Pharmacies
• Retail Pharmacies
• Blood Transfusion Centers
• Others

By Material Type

• Plastic
• PVC
• Polyethylene
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Terumo Corporation
• Becton, Dickinson and Company
• Fresenius Kabi AG
• Cardinal Health, Inc.
• Haemonetics Corporation
• Grifols S.A.
• Mediware Information Systems, Inc.
• Macopharma
• Blood Centers of America, Inc.
• JMS Co., Ltd.
• Shenzhen Dapeng Pharmaceutical Co., Ltd.
• Medline Industries, Inc.
• Graham-Field Health Products, Inc.
• SCW Medicath
• Biolife Plasma Services